- Published at
- by manilatimes.net
positive
positive
News for Aptose Biosciences Inc. (APS.TO)
- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveAptose Announces Auditor Not Standing for Re-Appointment | APTO Stock News
KPMG LLP will not be re-appointed as Aptose Biosciences' auditor for the 2025 annual audit. Decision was made unilaterally by KPMG due to material weakn- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by benzinga.com
mixedmixedNasdaq Surges 1%; US Construction Spending Rises In February - bioAffinity Technologies (NASDAQ:BIAF), Aptose Biosciences (NASDAQ:APTO)
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Tuesday. The Dow traded up 0.26% to 42,110.35 while the NAS...- Published at
- by benzinga.com
mixedmixedDow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - bioAffinity Technologies (NASDAQ:BIAF), Aptose Biosciences (NASDAQ:APTO)
U.S. stocks traded lower this morning, with the Dow Jones falling more than 400 points on Tuesday. Following the market opening Tuesday, the Dow traded down 1....- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveAptose Reports Year End 2024 Results and Corporate Highlights
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to Include i- Published at
- by gurufocus.com
positivepositive- Published at
- by gurufocus.com
mixedmixedBleichroeder LP Acquires Significant Stake in Aptose Biosciences Inc
On March 19, 2025, Bleichroeder LP (Trades, Portfolio) executed a notable transaction by acquiring 3,666,667 shares of Aptose Biosciences Inc (APTO) at a traded- Published at
- by gurufocus.com
mixedmixedAptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
SAN DIEGO and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (”Aptose” or the ”Company”) ( APTO, TSX: APS), a clinical-stage prec- Published at
- by benzinga.com
mixedmixedWhy Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Aptose Biosciences (NASDAQ:APTO), Aditxt (NASDAQ:ADTX)
Shares of Global Blue Group Holding AG GB rose sharply during Wednesday's pre-market trading session after the company announced it will be acquired by Shift4 f...- Published at
- by benzinga.com
mixedmixedUS Stocks Likely To Open Lower Following Fresh Records From Previous Session: Expert Says, 'Don't Be Scared Of New Highs' - Aptose Biosciences (NASDAQ:APTO), Analog Devices (NASDAQ:ADI)
U.S. stock futures fell on Wednesday after scaling fresh records on Tuesday. The futures of all four benchmark indices were trading lower.- Published at
- by gurufocus.com
positivepositiveAptose Announces Reverse Share Split
SAN DIEGO and TORONTO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (”Aptose” or the ”Company”) ( APTO, TSX: APS), a clinical-stage preci- Published at
- by benzinga.com
mixedmixedUS Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meet - Alibaba Gr Hldgs (NYSE:BABA), Aptose Biosciences (NASDAQ:APTO)
U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday.- Published at
- by benzinga.com
mixedmixedWhy GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Aptose Biosciences (NASDAQ:APTO), Aditxt (NASDAQ:ADTX)
Shares of GCL Global Holdings Ltd GCL rose sharply in today’s pre-market trading. GCL and RF Acquisition Corp. disclosed the successful completion of their b...- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Reduces Stake in Aptose Biosciences Inc
Significant Transaction by ARMISTICE CAPITAL, LLC (Trades, Portfolio) On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transa- Published at
- by financialpost.com
positivepositiveAptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
SAN DIEGO and TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision o…- Published at
- by manilatimes.net
positivepositive